Table 5.
QIs | Unadjusted | Adjusted | ||
---|---|---|---|---|
OR [95% CI] | P‐value | OR [95% CI] | P‐value | |
SQI‐1: Antipsychotic monotherapy | 1.16 [1.03–1.30] | 0.018 | 1.07 [0.94–1.22] | 0.31 |
SQI‐2: Antipsychotic monotherapy without other psychotropics | 1.15 [0.98–1.35] | 0.082 | 1.16 [0.98–1.39] | 0.089 |
SQI‐3: No prescription of anxiolytics or hypnotics | 1.14 [1.01–1.29] | 0.039 | 1.15 [1.00–1.31] | 0.049 |
CI, confidence interval; non‐EGUIDE, patients treated by psychiatrists who did not participate in the EGUIDE project; OR, Odds ratio; pre‐EGUIDE (+), patients treated by psychiatrists who had not yet attended the EGUIDE lecture; QI, quality indicator; SQI, quality indicator of schizophrenia. Confounding factors, age, sex, and type of facilities, were adjusted.